Compare Enveric Biosciences Inc (ENVB) vs TotalEnergies SE (TTE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs TotalEnergies SE — how do they compare? Enveric Biosciences Inc trades at $1.39 (market cap $5.32M), while TotalEnergies SE trades at $79.49 (market cap $178.73B). The key difference: TotalEnergies SE is far larger — about 33595.9× Enveric Biosciences Inc's market cap, and TotalEnergies SE pays a 5.25% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| ENVB | TTE | |
|---|---|---|
Market Cap | $5.32M | $178.73B |
Sector | Health | Energy |
52-Week High | $17.40 | $93.60 |
52-Week Low | $1.28 | $57.39 |
Enterprise Value | $408.82K | $212.87B |
Dividend Yield | — | 5.25% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.41, up 6.82% in the last session. The stock shows a bearish technical trend with moving averages signaling sell, but oscillators are neutral. Financially, the company reported a net loss of $8.77M for 2025, with negative ROE and ROA, though it consistently beat EPS expectations. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003.
Outlook is speculative with high risk due to negative profitability and cash burn, offset by strong analyst buy ratings (75%) and positive clinical updates. Key risks include funding needs and drug development hurdles, while catalysts hinge on regulatory milestones and partnership news.
TotalEnergies (TTE) trades at $80.91, down 0.37% on the day, with strong technical momentum indicated by a bullish moving average signal. The company maintains solid fundamentals with a P/E of 11.92 and ROE of 12.55%, though revenue has declined from $263.3B in 2022 to $182.3B in 2025. Recent news highlights strategic divestments and new energy project developments, while analyst consensus remains strongly positive with 19 buy ratings.
TTE presents a compelling value opportunity with attractive valuation metrics and consistent dividend payments. However, investors face risks from declining revenue trends, geopolitical exposure in oil-producing regions, and regulatory pressures on emissions. The stock's current technical strength and positive analyst sentiment suggest potential upside, but requires monitoring of operational execution and energy market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About TotalEnergies SE
TotalEnergies is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, it produced 1.5 million barrels of liquids and 7.2 billion cubic feet of natural gas per day. At year-end 2020, reserves stood at 12.1 billion barrels of oil equivalent, 45% of which are liquids. During 2021, it had LNG sales of 42 Mt. The company owns interests in refineries with capacity of nearly 1.8 million barrels a day, primarily in Europe, distributes refined products in 65 countries, and manufactures commodity and specialty chemicals. It also holds a 19% interest in Russian oil company Novatek. At year-end, its gross installed renewable power generation capacity was 10.3 GW.
Read more on TTE →
